Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
The invention features methods and compositions for preventing or treating pain resulting from surgery or an incision by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
1. A method for treating post-surgical pain in a human subject comprising administering to the subject in need of such treatment an effective amount of an antagonist of nerve growth factor (NGF), whereby the post-surgical pain in the subject is treated, and wherein the NGF antagonist is other than TrkA immunoadhesin.
2. The method of claim 1 , wherein the post-surgical pain comprises resting pain, and wherein the resting pain is ameliorated.
3. The method of claim 1 , wherein the post-surgical pain comprises mechanically-induced pain, and wherein the mechanically-induced pain is ameliorated.
4. The method of claim 1 , further wherein the NGF antagonist is other than an anti-NGF antibody.
5. The method of claim 1 , wherein the NGF antagonist is a kinase inhibitor capable of inhibiting downstream kinase signaling associated with NGF receptor activity.
6. The method of claim 5 , wherein the kinase inhibitor is K252a.
7. The method of claim 1 , wherein the post-surgical pain comprises resting pain and mechanically-induced pain, and wherein the resting pain and mechanically-induced pain are ameliorated.
8. The method of claim 1 , wherein the post-surgical pain comprises thermally-induced pain, and wherein the thermally-induced pain is ameliorated.
9. The method of claim 1 , wherein the post-surgical pain comprises resting pain, mechanically-induced pain, and thermally-induced pain, and wherein the resting pain, mechanically-induced pain, and thermally-induced pain are ameliorated.
10. The method of claim 1 , wherein wound healing is not significantly inhibited.